Trials / Completed
CompletedNCT01915173
Response to Supplement and Placebo in GERD
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Beth Israel Deaconess Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the effects of a widely available over the counter supplement marketed for heartburn symptoms on symptoms and health-related quality of life in patients with gastroesophageal reflux disease (GERD). This study is designed as a pilot trial to assess safety and feasibility and to provide preliminary estimates of effect sizes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Supplement | Abies nigra 4C, Carbo vegetabilis 4C, Nux vomica 4C, and Robinia pseudoacacia 4C |
| DRUG | Placebo | Lactose tablets |
| BEHAVIORAL | Expanded Interview | |
| BEHAVIORAL | Standard Interview |
Timeline
- Start date
- 2013-06-01
- Primary completion
- 2014-04-01
- Completion
- 2014-04-01
- First posted
- 2013-08-02
- Last updated
- 2017-03-29
- Results posted
- 2017-03-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01915173. Inclusion in this directory is not an endorsement.